Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Brain Diseases » Cerebrovascular Disorders » Stroke
Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Cerebrovascular Disorders » Stroke
Description
A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810) MeSH
Hierarchy View
Subtype Terms (3)
Brain Infarction
13 drugs (8 approved, 5 experimental)
Hemorrhagic Stroke
19 drugs (14 approved, 5 experimental)
Ischemic Stroke
273 drugs (134 approved, 139 experimental)
Approved Indicated Drugs (50)
Phase 4 Indicated Drugs (82)
Phase 3 Indicated Drugs (59)
Phase 2 Indicated Drugs (91)
allogeneic adipose derived mesenchymal stem cell
autologous mesenchymal stem cells
autologous mononuclear stem cell
autologous umbilical cord blood
Other Experimental Indicated Drugs (47)
Organization Involved with Phase 4 Indications (257)
Ankang Hospital of Traditional Chinese Medicine
Anyue County Hospital of Traditional Chinese
Beijing Bionovo Medicine Development Co., Ltd.
Beijing Bozhiyin T&S Co., Ltd.
Boryung Pharmaceutical Company
Burnasyan Federal Medical Biophysical Center
Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine
Chengdu Integrated TCM & Western Medicine Hospital
Chengdu University of Traditional Chinese Medicines
China Academy of Chinese Medical Sciences
China Food and Drug Administration
City Hospitals Sunderland NHS Foundation Trust
Clinical Institute of the Brain, Russia
Combination Therapy for Acute Ischemic Stroke Study Group
Conghua city hospital of Traditional Chinese Medicine
Cristália Produtos Químicos Farmacêuticos Ltda.
Department of Health, United Kingdom
Dongguan city hospital of traditional chinese medicine
Foshan Hospital of Traditional Chinese Medicine
Fundação de Amparo à Pesquisa do Estado de São Paulo
Fundació IMIM - Parc de Salut Mar
Ganzhou People's Hospital Affiliated to Nanchang University
Guagnzhou Liwan district Hospital of TCM
Guangdong Provincial Hospital of Traditional Chinese Medicine
Guangdong Second Provincial Traditional Chinese Medicine Hospital
Guangyuan city hospital of Traditional Chinese Medicine
Guangzhou Baiyunshan Qixing Pharmaceutical Co Ltd
Guangzhou University of Chinese Medicine
Helena Laboratories Point of Care
Henan University of Traditional Chinese Medicine
Hoosier Cancer Research Network
Hospital general Universitario de Ciudad Real
Hospital Joan XXIII de Tarragona, Tarragona, Spain
Hospital Universitario Arnau de Vilanova de Lleida
Hospital Universitario de Albacete
Hospital Universitari Son Dureta
Huazhong University of Science and Technology
Hubei University of Chinese Medicine
Huizhou People's Central Hospital
Hunan Academy of Chinese Medicine
Hunan University of Traditional Chinese Medicine
Icahn School of Medicine at Mount Sinai
idv Datenanalyse und Versuchsplanung
Institut Hospital del Mar d'Investigacions Mèdiques
Japan Cardiovascular Research Foundation
Jiangmen Wuyi Hospital of Traditional Chinese Medicine
Jiangsu Kanion Pharmaceutical Co., Ltd
Jiangxi Provincial People's Hospital
Lianjiang Hospital of Traditional Chinese Medicine
Lianyungang Chinese Medicine Hospital
Liaoning Hospital of Traditional Chinese Medicine
Liling Hospital of Traditional Chinese Medicine
Lishui Country People's Hospital
Maoming city hospital of Traditional Chinese Medicine
Mianyang city hospital of traditional chinese medicine
Nanhai Hospital of Traditional Chinese Medicine
National Cerebral and Cardiovascular Center
National Cheng Kung University
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Neuroscience Institute
National Rehabilitation Center of Korea
Network for Clinical Stroke Trials
Norwegian Underwater Intervention (NUI)
People's hospital of Huizhou city
People's hospital of Jianyang city
People's Liberation Army of China
Qishan county hospital of shaanxi province
Second People's Hospital of Yibin
Shaanxi Provincial People's Hospital
Shaanxi University of Chinese Medicine
Shahid Beheshti University of Medical Sciences
Shandong University of Traditional Chinese Medicine
Shanghai Municipal Science and Technology Commission
Shanghai University of Traditional Chinese Medicine
Shanxi College of Traditional Chinese Medicine
Shineway Pharmaceutical Co.,Ltd
Shin Kong Wu Ho-Su Memorial Hospital
Taipei Veteran General hospital
Taishan city hospital of Traditional Chinese Medicine
The Airport Hospital of Shunyi District
The First Hospital of Handan City
The First Hospital of Qiqihar City
The NO.4 People's Hospital of Hengshui
Thoracic & Cardiovascular Healthcare Foundation, Lansing, MI
Tianjin University of Traditional Chinese Medicine
Tianshui Hospital of Traditional Chinese Medicine
Universidad Autonoma de Barcelona
Universidad Complutense de Madrid
University of Eastern Piedmont
URUMQI Hospital of Traditional Chinese Medicine
Western Norway University of Applied Sciences
Wuxi Hospital of Traditional Chinese Medicine
Wuzhou city red cross hospital
Xinhui hospital of Traditional Chinese Medicine, Jiangmen
Xinxing county hospital of Traditional Chinese Medicine
Yangjiang Hospital of Traditional Chinese Medicine
Yuexiu district hospital of Traditional Chinese Medicine
Organization Involved with Phase 3 Indications (200)
Aase and Ejnar Danielsens Foundation
Atrium Medisch Centrum, Heerlen
Badalona Hospital Germans Trias i Pujol
Bert Spilker & Associates, LLC
Canadian Institutes of Health Research (CIHR)
Canadian Stroke Consortium (CSC)
Centre Hospitalier Sainte-Anne
Charitable Trust Mihara Cerebrovascular Disorder Research Promotion Fund
China National Biotec Group Co., Ltd
Chinese Academy of Medical Sciences
Chinese University of Hong Kong
Clinical Research Centre Hospital Taiping
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Daewoong Pharmaceutical Co. LTD.
Danish National Research Foundation
Dexa Laboratories Of Biomolecular Science
Duta Wacana Christian University
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez
Foundation to Promote Research into Functional Vitamin B12 Deficiency, Bergen, Norway
Fundacion Clinic per a la Recerca Biomédica
Hamilton Health Sciences Corporation
Health Research Board, Ireland
Hospital Santa Marcelina, Sao Paulo, Brasil
Indonesia's Neurologists Organization (Perdossi)
Japan Agency for Medical Research and Development
Katholieke Universiteit Leuven
Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
Korea Institute of Science and Technology
Mazandaran University of Medical Sciences
Medical University of South Carolina
Murtala Muhammed Specialist Hospital
National Cancer Institute (NCI)
National Institutes of Health (NIH)
National Research Council of Thailand
National University of Ireland
National University of Singapore
Neurological Emergencies Treatment Trials Network
Norwegian Heart and Lung Patient Organisation
Pirogov Russian National Research Medical University
Scienze Neurologiche Ospedaliere
Seberang Jaya Clinical Research Centre
Simcere Pharmaceutical Co., Ltd
Singapore University of Technology and Design
South-Eastern Norway Regional Health Authority
Swiss National Science Foundation
The Stroke Association, United Kingdom
The University of Texas, Dallas
Thrombolysis in Myocardial Infarction Study Group
Translational Research Informatics Center, Kobe, Hyogo, Japan
University Hospital of North Norway
University of British Columbia
University of California, Los Angeles
University of California, San Diego
University of California, San Francisco
University of Erlangen-Nuremberg
University of Medicine and Dentistry of New Jersey
University of North Carolina at Chapel Hill
University of Science Malaysia
Organization Involved with Phase 2 Indications (182)
All India Institute of Medical Sciences
Andalusian Initiative for Advanced Therapies
Angde Biotech Pharmaceutical Co., Ltd.
Apeloa Pharmaceutical Co. Ltd.
Applied Health Research Centre
Aristotle University of Thessaloniki
Cantonal Hospital of St. Gallen
Case Western Reserve University
Cellonis Biotechnology Co. Ltd.
Chandler Regional Medical Center at Chandler AZ
Cheng Hsin Rehabilitation Medical Center
City Hospital No 40, Saint Petersburg, Russia
CSSS Champlain - Charles-Lemoyne Hospital
Federal University of Rio Grande do Sul
Genervon Biopharmaceuticals, LLC
Guangzhou Recomgen Biotech Co., Ltd.
Gwo Xi Stem Cell Applied Technology Co., Ltd.
Hoag Memorial Hospital Presbyterian
Hospital Raja Permaisuri Bainun
Hunan Rui Kang Tong technology development co., LTD
Inner Mongolia Baogang Hospital
Institut National de la Santé Et de la Recherche Médicale, France
KAUTERS HOSPITAL SEBERANG JAYA
Korea Evaluation Institute of Industrial Technology
Memorial University of Newfoundland
Nanjing University of Traditional Chinese Medicine
Nanyang Technological University
National Center for Advancing Translational Science (NCATS)
National Institute for Health Research, United Kingdom
National Stroke Research Institute, Australia
Oregon Health and Science University
Postgraduate Institute of Medical Education and Research
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Second People's Hospital of Nanhai District of Foshan
Shijiazhuang Pharma Group (CSPC)
Stempeutics Research Malaysia SDN BHD
Subei People's Hospital of Jiangsu Province
Sygnis Bioscience GmbH & Co KG
Taichung Veterans General Hospital
The Central Hospital of Lishui City
The Danish Regions Medicine Foundation
The Florey Institute of Neuroscience and Mental Health
The Florey Institute of Neuroscience & Mental Health Melbourne Brain Centre
The University of Texas Health Science Center, Houston
Thrombolytic Science International
Universidad Autonoma de Madrid
University of Alabama, Birmingham
University of California, Irvine
University of Southern California
University of Texas, San Antonio
Vancouver Island Health Authority
ZonMw: The Netherlands Organisation for Health Research and Development
Organization Involved with Phase 1 Indications (65)
Allife Medical Science and Technology Co., Ltd.
Assistance Publique - Hôpitaux de Paris
China Spinal Cord Injury Network
Etablissement Français du Sang
Ever Supreme Bio Technology Co., Ltd.
Global Neurosciences Institute
Hospital Hernando Moncaleano Perdomo
Hospital Universitario Hernando Moncaleano Perdomo
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Instituto de Estudios de Ciencias de la Salud de Castilla y León (IECSCYL)
Memorial Hermann Health System
National Institute on Aging (NIA)
Neurogen Brain and Spine Institute
North East Ambulance Service NHS Trust
Northumbria Healthcare NHS Foundation Trust
Organization Involved with Other Experimental Indications (42)
Adolphe Rothschild Ophtalmologic Foundation
City Clinical Hospital No. 67, Moscow, Russia
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Medical Health Research Infrastructure Council, Australia
National Heart Foundation, Australia
New York Presbyterian Hospital
Nizam's Institute of Medical Sciences, Hyderabad, India
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
